Weโre proud to unveil our newest peer-reviewed research, published in the American Journal of Biomedical Science & Research โ a breakthrough exploration into the treatment of Retinitis Pigmentosa (RP)!
๐ Publication Title: Recalibrating Retinal Immunity: Peptide-Based Strategies for Durable Vision Preservation in Retinitis Pigmentosa
โ๏ธ Authors: Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Krista Casazza, Waldemar Lernhardt, Dr. Dmytro Klokol, Ian Jenkins, and Jonathan R.T. Lakey
Watch the video: https://youtube.com/shorts/-rsm5dHha8s
๐ Read the full paper here: https://european-wellness.eu/publications/recalibrating-retinal-immunity/
Led by European Wellness scientists Prof. Datoโ Sri Dr. Mike Chan, Prof. Datoโ Sri Dr. Michelle Wong, and Prof. Dr. Dmytro Klokol, in collaboration with top researchers from UC Irvine and GATC Health, this groundbreaking paper presents powerful new insights into how peptide therapeutics could potentially halt โ and even reverse โ vision loss caused by RP.
What this research reveals: ๐น RP isnโt just genetic โ inflammation, oxidative stress, and immune dysfunction accelerate degeneration. ๐น Bioactive peptides (like thymosin ฮฒ4 and KPV) can potentially retrain the immune system and promote retinal repair. ๐น A breakthrough technique called Antigen Adaptive Selective Immunotherapy (AASI) may potentially stop immune attacks on retinal cells โ restoring immune balance without suppressing the whole immune system. ๐น Next-gen delivery systems are enhancing peptide stability, precision, and efficacy โ offering new hope for long-term visual preservation.
This is a huge leap forward in the race to help patients affected by RP โ and it opens the door to similar strategies for other neurodegenerative eye diseases. A game-changer in the making!
๐ Read more here: https://european-wellness.eu/publications/recalibrating-retinal-immunity/ ๐ Explore more EW publications: https://european-wellness.eu/publications/